Chair:
Elizabeth Manias RN, BPharm, MPharm, MNStud, PhD, FRCNA, MPS, Professor, Associate Head of Research, School of Nursing and Social Work, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Carlton, Victoria, Australia

Leadership Group:
Dyfrig Hughes, PhD, MRPharmS, Reader in Pharmacoeconomics and Deputy Director, Centre for Economics and Policy in Health, IMSCaR, Bangor University
Femida Gwadry-Sridhar PhD, RPh, MSc, BSc Phm, Assistant Professor, Departments of Medicine and Physiology & Pharmacology, University of Western Ontario; Assistant Professor, Department of Clinical Epidemiology & Biostatistics, McMaster University; Associate Director, Critical Care Research Network; Director of Health Informatics, Lawson Health Research Institute; CIHR New Investigator - Knowledge Translation
Andrew Peterson PharmD, Associate Professor, University of the Sciences in Philadelphia
Anuja Roy MBA, MSc
Josh Benner PharmD, ScD, Principal, IMS Consulting
Kristina Yu-Isenberg PhD, RPh, MSc, Director, Business Development, GlaxoSmithKline
Michael. B. Nichol PhD, Professor, University of Southern California
Ying Zhang PhD, Acadia University
Allison Williams PhD, RN, Research Fellow, The University of Melbourne, Victoria, Australia

1. Analysis Standards are being developed for Retrospective Analyses and Prospective Analyses
   A. Analyses of Retrospectively Acquired Data
       > A Checklist for Medication Compliance an Persistence Studies Using Retrospective Databases
       > Manuscript accepted by Value in Health
   Citation: Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007 Jan-Feb;10(1):3-12
   
   B. Analyses of Prospectively Acquired Data (Checklist and Manuscript in preparation)
    
2. Assessment of the general aspects relating to properties of compliance measures: detailing the different measures used in assessing compliance and the implications for their use. The manuscript will also address some of the variants in the literature and how these measures may impact on data analyses (Manuscript in preparation)

1. Possible development of a short course in medication compliance and persistence at a future annual international meeting (in conjunction with other Working Groups of the Medication Compliance and Persistence Special Interest Group).
   
   
2. Writing of a paper examining knowledge translation in practice and implications for policy initiatives.
   
   
3. Systematic review of literature on compliance measures.